This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BRANFORD, Conn., Nov. 1, 2010 (GLOBE NEWSWIRE) --
CAS Medical Systems, Inc. (Nasdaq:CASM) announced today that Gregory P. Rainey was appointed to the CASMED Board of Directors effective October 28, 2010. Mr. Rainey brings broad expertise in the healthcare field to his Board position with more than 25 years experience in medical products selling organizations.
"We are pleased to have someone of Mr. Rainey's caliber join our Board," said Louis P. Scheps, Chairman of the Board of CASMED. "Mr. Rainey is well respected in the medical products industry and will be an asset to the Board and to the Company. With four new Board members appointed in the last few years, CASMED now has broader and more complementary expertise which can provide new perspectives as we help guide the Company's corporate strategies."
Since 2004, Mr. Rainey has been the President of CCI Performance Group, LLC, which provides consulting services for healthcare companies on sales management and product distribution strategies. CCI's clients range from Fortune 500 companies to medical device start-ups. Prior to 2004, Mr. Rainey worked for Stryker Corporation in various roles including many years as Vice President of Sales and as a member of the Executive Committee of its $1.2 billion orthopedic division. Mr. Rainey is also a member of the Board of Directors of RTI Biologics, Inc.
"I am thrilled to have Mr. Rainey on our Board and look forward to working with him," said Thomas M. Patton, President and CEO of CASMED. "As an organization that has industry leading technologies, CASMED can benefit from the insights of a sales professional with Mr. Rainey's experience as we develop plans to more fully penetrate and expand the markets for our products."
About CASMED ® - Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information provides medical professionals important information during surgery and other critical care situations to enable them to react to low levels of cerebral oxygen and intervene to prevent severe injury, impairment, and even death.